6.0513
price down icon4.85%   -0.3087
 
loading

Nuvectis Pharma Inc Borsa (NVCT) Ultime notizie

pulisher
10:22 AM

Nuvectis Pharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener

10:22 AM
pulisher
09:54 AM

Nuvectis Pharma Doubles Down On R&D Despite Rising Losses - Finimize

09:54 AM
pulisher
08:25 AM

Nuvectis Pharma Q3 net loss widens on milestone expenses - MarketScreener

08:25 AM
pulisher
08:15 AM

Nuvectis Pharma (NASDAQ: NVCT) posts third quarter results: $7.5M net loss; runway to 3Q-2027 - Stock Titan

08:15 AM
pulisher
08:03 AM

Nuvectis Pharma, Inc. SEC 10-Q Report - TradingView

08:03 AM
pulisher
07:45 AM

Nuvectis Pharma reveals Q3 2025 financial performance and strategic business updates - Traders Union

07:45 AM
pulisher
07:30 AM

Nuvectis Pharma (NASDAQ: NVCT) initiates NXP900 Phase 1b; cash at $35.4M in Q3 results - Stock Titan

07:30 AM
pulisher
01:39 AM

What makes Nuvectis Pharma Inc. stock attractive to growth fundsJuly 2025 Setups & Detailed Earnings Play Alerts - newser.com

01:39 AM
pulisher
Nov 03, 2025

Does Nuvectis Pharma Inc. qualify in momentum factor screeningMarket Performance Summary & Fast Exit and Entry Strategy Plans - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is Nuvectis Pharma Inc a good long term investmentStock Split Announcements & High Yield Market Growth - earlytimes.in

Nov 03, 2025
pulisher
Nov 03, 2025

Why Nuvectis Pharma Inc. stock remains undervaluedEarnings Summary Report & Fast Moving Trade Plans - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Nuvectis Pharma Inc. stock trendline breakdownJuly 2025 Recap & Free Technical Pattern Based Buy Signals - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

How strong is Nuvectis Pharma Inc. stock revenue growthJuly 2025 Short Interest & Weekly Return Optimization Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

How Nuvectis Pharma Inc. stock performs in rate cut cyclesJuly 2025 Sector Moves & Community Consensus Trade Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Using RSI to spot recovery in Nuvectis Pharma Inc.July 2025 Spike Watch & Capital Protection Trading Alerts - newser.com

Nov 03, 2025
pulisher
Nov 02, 2025

Predicting Nuvectis Pharma Inc. trend using moving averagesJuly 2025 Recap & Entry Point Confirmation Signals - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

What data driven models say about Nuvectis Pharma Inc.’s futureBull Run & Safe Capital Growth Stock Tips - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

Nuvectis Pharma Shares: Poised for Significant Growth? - AD HOC NEWS

Nov 01, 2025
pulisher
Oct 31, 2025

Nuvectis Pharma : Initial Statement of Beneficial Ownership (Form 3) - MarketScreener

Oct 31, 2025
pulisher
Oct 30, 2025

Insider Buying: Nuvectis Pharma (NASDAQ:NVCT) Major Shareholder Acquires 46,900 Shares of Stock - MarketBeat

Oct 30, 2025
pulisher
Oct 30, 2025

Nuvectis Pharma (NASDAQ:NVCT) Major Shareholder Purchases $215,459.10 in Stock - MarketBeat

Oct 30, 2025
pulisher
Oct 30, 2025

A US$22m Market Cap Boost Pleasing ToNuvectis Pharma Insiders - simplywall.st

Oct 30, 2025
pulisher
Oct 30, 2025

What's Driving Renewed Interest In Nuvectis Pharma's Oncology Strategy? - RTTNews

Oct 30, 2025
pulisher
Oct 29, 2025

Major Investment Alert: Insider Buys Big in Nuvectis Pharma! - TipRanks

Oct 29, 2025
pulisher
Oct 29, 2025

Insider Stock Purchases: October 29, 2025 - Quiver Quantitative

Oct 29, 2025
pulisher
Oct 29, 2025

Nuvectis Pharma Stock (NVCT) Opinions on NXP900 Trial Results - Quiver Quantitative

Oct 29, 2025
pulisher
Oct 29, 2025

Nuvectis Pharma (NVCT) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat

Oct 29, 2025
pulisher
Oct 29, 2025

Nuvectis Pharma Insider Bought Shares Worth $957,083, According to a Recent SEC Filing - MarketScreener

Oct 29, 2025
pulisher
Oct 28, 2025

Nuvectis Pharma’s Phase 1 Study of NXP900: A Potential Game-Changer in Cancer Treatment - The Globe and Mail

Oct 28, 2025
pulisher
Oct 28, 2025

Can Nuvectis Pharma Inc. stock hit analyst price targetsMarket Volume Summary & Daily Technical Forecast Reports - fcp.pa.gov.br

Oct 28, 2025
pulisher
Oct 28, 2025

H.C. Wainwright reiterates Buy rating on Nuvectis Pharma stock at $10 target - Investing.com Nigeria

Oct 28, 2025
pulisher
Oct 28, 2025

H.C. Wainwright reiterates Buy rating on Nuvectis Pharma stock at $10 target By Investing.com - Investing.com South Africa

Oct 28, 2025
pulisher
Oct 28, 2025

Can Nuvectis Pharma Inc. stock reach $100 price targetJuly 2025 Institutional & Free Technical Pattern Based Buy Signals - fcp.pa.gov.br

Oct 28, 2025
pulisher
Oct 28, 2025

Will Nuvectis Pharma Inc. stock beat EPS estimatesWatch List & Consistent Growth Equity Picks - newser.com

Oct 28, 2025
$37.95
price up icon 1.71%
$29.15
price up icon 1.67%
$102.08
price up icon 0.58%
$103.42
price down icon 0.49%
biotechnology ONC
$315.16
price up icon 1.13%
$185.89
price down icon 0.42%
Capitalizzazione:     |  Volume (24 ore):